Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.37 EUR | +0.24% | -2.34% | -3.07% |
May. 31 | Qiagen, Myriad Genetics Team Up to Develop Homologous Recombination Deficiency Test | MT |
May. 31 | Qiagen, Myriad Genetics Partner to Create Easily Distributable Cancer Tumor Test | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
QIAGEN N.V. | Other Biotechnology & Medical Research | +0.24% | -2.34% | -3.07% | -9.53% | +11.79% | 9.6B | - | - | - |
- Stock Market
- Equities
- QGEN Stock
- QIA Stock
- Charts Qiagen N.V.
- Relative Strength Chart